Fellowship · Minneapolis, MN
Sponsored by University of Minnesota
A Review of Theranostics: Perspectives on Emerging Approaches and Clinical Advancements.
Radiology. Imaging cancer · 2023 · 144 citations · Ayse Kendi
Quantitative 68Ga-PSMA-11 PET and Clinical Outcomes in Metastatic Castration-resistant Prostate Cancer Following 177Lu-PSMA-617 (VISION Trial).
Radiology · 2024 · 97 citations · Ayse Kendi
Critical updates in neuroendocrine tumors: Version 9 American Joint Committee on Cancer staging system for gastroenteropancreatic neuroendocrine tumors.
CA: a cancer journal for clinicians · 2024 · 72 citations · Ayse Kendi
Theranostics and artificial intelligence: new frontiers in personalized medicine.
Theranostics · 2024 · 78 citations · Ayse Kendi
Targeted Alpha-Particle Therapy: A Review of Current Trials.
International journal of molecular sciences · 2023 · 81 citations · Ayse Kendi
Health-related quality of life and pain outcomes with [177Lu]Lu-PSMA-617 plus standard of care versus standard of care in patients with metastatic castration-resistant prostate cancer (VISION): a multicentre, open-label, randomised, phase 3 trial.
The Lancet. Oncology · 2023 · 95 citations · Ayse Kendi
Status of PSMA-targeted radioligand therapy in prostate cancer: current data and future trials.
Therapeutic advances in medical oncology · 2023 · 78 citations · Ayse Kendi
Lymphadenopathy in COVID-19 Vaccine Recipients: Diagnostic Dilemma in Oncologic Patients.
Radiology · 2021 · 129 citations · Can Ozutemiz, Luke Krystosek, Daniel Steinberger